Quince Therapeutics, Inc. (QNCX)
(Delayed Data from NSDQ)
$1.67 USD
+0.01 (0.60%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $1.68 +0.01 (0.60%) 6:38 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Quince Therapeutics, Inc. has a market cap of $89.02M, which represents its share price of $1.66 multiplied by its outstanding shares number of 53.62M. As a small-cap company, QNCX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
QNCX 1.67 +0.01(0.60%)
Will QNCX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QNCX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for QNCX
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for ...
QNCX: JMP Securities Initiates Coverage with Market Outperform Rating | QNCX Stock News
This Lionsgate Studios Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Quince Therapeutics (QNCX) Receives Positive Coverage with Strong Growth Potential
Quince Therapeutics initiated with an Outperform at Citizens JMP